BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6119925)

  • 21. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nadolol: its use in the prophylactic treatment of migraine.
    Ryan RE; Ryan RE; Sudilovsky A
    Headache; 1983 Jan; 23(1):26-31. PubMed ID: 6131052
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
    Himber J; Sallee VL; Andermann G; Bouzoubaa M; Leclerc G; De Santis L
    J Ocul Pharmacol; 1987; 3(2):111-20. PubMed ID: 2903204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiglaucomatous effectiveness of beta receptor blockers with special reference to metipranolol].
    Noack E
    Klin Monbl Augenheilkd; 1986 Jul; 189(1):1-3. PubMed ID: 2876128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.
    Ros FE; Dake CL; Offerhaus L; Greve EL
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Dec; 205(1):61-70. PubMed ID: 341739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma.
    Berrospi AR; Leibowitz HM
    Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimolol: effect on intraocular pressure in chronic open-angle glaucoma.
    Obstbaum SA; Galin MA; Katz IM
    Ann Ophthalmol; 1978 Oct; 10(10):1347-51. PubMed ID: 31126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
    Weth G; Schneider J; Rodatz H; Haubitz I
    Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)].
    Oancea I
    Klin Monbl Augenheilkd; 1975 Oct; 167(4):618-22. PubMed ID: 1574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trials in pressure regulation with metipranolol eyedrops in special forms of glaucoma in ophthalmologic practice].
    Demmler N
    Klin Monbl Augenheilkd; 1983 Feb; 182(2):153-5. PubMed ID: 6133028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of betaxolol and nadolol on renal function in essential hypertension.
    Bauer JH; Reams GP; Lau A
    Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thymoptic in the treatment of glaucoma].
    Koretskaia IuM; Bel'fer IM; Guzeĭ LA; Govorun SI
    Vestn Oftalmol; 1982; (3):11-2. PubMed ID: 6126024
    [No Abstract]   [Full Text] [Related]  

  • 36. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
    Ryan RE
    Am Heart J; 1984 Oct; 108(4 Pt 2):1156-9. PubMed ID: 6148878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaninolol: a novel compound for the treatment of glaucoma and ischemic retinopathy.
    Wu BN; Hong SJ; Sheu MM; Chen IJ; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):213-20. PubMed ID: 8590252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.